COMMUNIQUÉS West-GlobeNewswire

Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
12/08/2025
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission [...]
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 552%, This Marks Juvent’s First Time on the List CHATTANOOGA, Tenn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
TRYVIO nominated for the 2025 Prix Galien USA “Best Pharmaceutical Product”
12/08/2025
Allschwil, Switzerland – August 12, 2025 Idorsia Ltd (SIX: IDIA) announced today that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated TRYVIO™ ( [...]
Birches Health, a leading clinical provider of Gambling Addiction care, expands statewide access to specialized Problem Gambling treatment across Nevada
12/08/2025
LAS VEGAS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Using funding from the Nevada Division of Public and Behavioral Health (DPBH), Birches Health today launched a groundbreaking program focused on expanding access to evidence- [...]
Compass Health announces completion of first-ever capital campaign to fund state-of-the-art facility for intensive behavioral health services
12/08/2025
The campaign supported the construction of the Marc Healing Center, Phase II of Compass Health’s Broadway Campus Redevelopment EVERETT, Wash., Aug. 12, 2025 (GLOBE NEWSWIRE) -- When Compass Health set out to build a [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2025
12/08/2025
Aggregated presentation by day and by market Statement of transactions in own shares from August 4th to August 8th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2025
12/08/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 04 août au 08 août 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
12/08/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 12 août 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
HealthEx Launches Platform to Empower Patients with Real-time Health Record Access in Collaboration with Industry Leaders
12/08/2025
New platform delivers on CMS vision and industry’s urgent need for end-to-end health data interoperability and a patient-centric healthcare ecosystem HealthEx leads a cross-industry effort with athenahealth, CLEAR, [...]
Health system adoption of AI outpaces internal governance and strategy
12/08/2025
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eighty-eight percent of health systems are using Artificial Intelligence internally, and 71% have identified and deployed pilot or full solutions in finance, revenue cycle [...]
AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 755 Percent, This Marks AscellaHealth’s 4th Time on the List BERWYN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
SoldierStrong Joins Face the Fight® Coalition to Combat Veteran Suicide
12/08/2025
STAMFORD, Conn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The national nonprofit SoldierStrong has been accepted as a member of the Face the Fight coalition, co-founder and chairman Dr. Chris Meek said today. This partnership [...]
San Diego Charity Golf Tournament at Maderas Golf Club to Support Veterans, First Responders, and NUCCA Awareness
12/08/2025
Dr. Vivek Soham and the Origin Vitae Network Host The Guardian Classic Charity Golf Tournament on September 8th, 2025 SAN DIEGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- On Monday, September 8th, 2025, the rolling greens of [...]
WeightWatchers Launches Inaugural Awards, Honoring Top Picks in Health and Wellness Products
12/08/2025
A New Mark of Excellence in Health and Wellness, WeightWatchers Awards Feature Products Curated by Experts and Trusted by Millions of Members NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: [...]
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
12/08/2025
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, announced today that it has commenced [...]
Women’s Health Collective Canada and Shoppers Foundation for Women’s Health™ Deepen Partnership with $1 Million Commitment to Health Research and Care
12/08/2025
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Shoppers Foundation for Women’s Health™ is building on its commitment to advancing health equity for women with a $1 million investment in health research and care, over the [...]
L’Association canadienne pour l’équité en santé des femmes et la Fondation Pharmaprix pour la santé des femmes(MD) renforcent leur partenariat par une promesse de don d’un million de dollars pour la recherche et les soins en santé
12/08/2025
TORONTO, 12 août 2025 (GLOBE NEWSWIRE) -- Fidèle à sa mission, la Fondation Pharmaprix pour la santé des femmes MD entend promouvoir l’équité en matière de santé des femmes par un investissement d’un million de dollars [...]
Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development
12/08/2025
Mike Andriole brings approximately 25 years of experience in the biopharmaceutical industry and a successful track record of delivering new first-in-class oncology therapies in indications of high unmet need to patients [...]
Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia
12/08/2025
Access the “What This Means” segment here SOUTH SAN FRANCISCO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next- [...]

Pages